{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:12:21Z","timestamp":1785816741373,"version":"3.56.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10875-025-01876-0","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T17:53:08Z","timestamp":1742233988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Deficiency of Adenosine Deaminase 2 Masquerading as Beh\u00e7et\u2019s Disease: Phenotypic Mimicry with HLA-B*51 Positivity"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4208-4196","authenticated-orcid":false,"given":"Abdullah","family":"Almojali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9626-1931","authenticated-orcid":false,"given":"Abdulrahman","family":"Alrasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7196-7267","authenticated-orcid":false,"given":"Bushra","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3888-7850","authenticated-orcid":false,"given":"Reem","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2477-1021","authenticated-orcid":false,"given":"Wafaa","family":"Alsuwairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5271-0002","authenticated-orcid":false,"given":"Fayhan","family":"Alroqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6467-6972","authenticated-orcid":false,"given":"Jubran","family":"Alqanatish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"issue":"10","key":"1876_CR1","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","volume":"370","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Yang D, Ombrello AK, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370(10):911\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1307361.","journal-title":"N Engl J Med"},{"issue":"10","key":"1876_CR2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","volume":"370","author":"P Navon Elkan","year":"2014","unstructured":"Navon Elkan P, Pierce SB, Segel R, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370(10):921\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1307362.","journal-title":"N Engl J Med"},{"issue":"1","key":"1876_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jaci.2021.04.034","volume":"149","author":"H Jee","year":"2022","unstructured":"Jee H, Huang Z, Baxter S, et al. Comprehensive analysis of ADA2 genetic variants and estimation of carrier frequency driven by a function-based approach. J Allergy Clin Immunol. 2022;149(1):379\u201387. https:\/\/doi.org\/10.1016\/j.jaci.2021.04.034.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1876_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1189\/jlb.1109764","volume":"88","author":"AV Zavialov","year":"2010","unstructured":"Zavialov AV, Gracia E, Glaichenhaus N, Franco R, Zavialov AV, Lauvau G. Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol. 2010;88(2):279\u201390. https:\/\/doi.org\/10.1189\/jlb.1109764.","journal-title":"J Leukoc Biol"},{"issue":"Pt 1","key":"1876_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1042\/BJ20050683","volume":"391","author":"AV Zavialov","year":"2005","unstructured":"Zavialov AV, Engstr\u00f6m A. Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity. Biochem J. 2005;391(Pt 1):51\u20137. https:\/\/doi.org\/10.1042\/BJ20050683.","journal-title":"Biochem J"},{"issue":"5","key":"1876_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","volume":"38","author":"I Meyts","year":"2018","unstructured":"Meyts I, Aksentijevich I. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment. J Clin Immunol. 2018;38(5):569\u201378. https:\/\/doi.org\/10.1007\/s10875-018-0525-8.","journal-title":"J Clin Immunol"},{"issue":"7","key":"1876_CR7","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/sj.cdd.4402132","volume":"14","author":"BB Fredholm","year":"2007","unstructured":"Fredholm BB. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 2007;14(7):1315\u201323. https:\/\/doi.org\/10.1038\/sj.cdd.4402132.","journal-title":"Cell Death Differ"},{"issue":"4","key":"1876_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1182\/blood.2018892752","volume":"134","author":"C Carmona-Rivera","year":"2019","unstructured":"Carmona-Rivera C, Khaznadar SS, Shwin KW, et al. Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2. Blood. 2019;134(4):395\u2013406. https:\/\/doi.org\/10.1182\/blood.2018892752.","journal-title":"Blood"},{"issue":"7","key":"1876_CR9","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s10875-023-01521-8","volume":"43","author":"MVE Andriessen","year":"2023","unstructured":"Andriessen MVE, Legger GE, Bredius RGM, et al. Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 Cohort. J Clin Immunol. 2023;43(7):1581\u201396. https:\/\/doi.org\/10.1007\/s10875-023-01521-8.","journal-title":"J Clin Immunol"},{"issue":"2","key":"1876_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s10875-022-01364-9","volume":"43","author":"F Alabbas","year":"2023","unstructured":"Alabbas F, Alanzi T, Alrasheed A, et al. Genotype and Phenotype of Adenosine Deaminase 2 Deficiency: a Report from Saudi Arabia. J Clin Immunol. 2023;43(2):338\u201349. https:\/\/doi.org\/10.1007\/s10875-022-01364-9.","journal-title":"J Clin Immunol"},{"key":"1876_CR11","doi-asserted-by":"publisher","unstructured":"Lee PY, Davidson BA, Abraham RS, et al. Evaluation and Management of Deficiency of Adenosine Deaminase 2: An International Consensus Statement. JAMA Netw Open. 2023;6(5):e2315894. Published 2023 May 1. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.15894","DOI":"10.1001\/jamanetworkopen.2023.15894"},{"issue":"9","key":"1876_CR12","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/art.39699","volume":"68","author":"S Nanthapisal","year":"2016","unstructured":"Nanthapisal S, Murphy C, Omoyinmi E, et al. Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases. Arthritis Rheumatol. 2016;68(9):2314\u201322. https:\/\/doi.org\/10.1002\/art.39699.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"1876_CR13","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1007\/s10067-020-05210-4","volume":"39","author":"S Ganh\u00e3o","year":"2020","unstructured":"Ganh\u00e3o S, Loureiro GB, Oliveira DR, et al. Two cases of ADA2 deficiency presenting as childhood polyarteritis nodosa: novel ADA2 variant, atypical CNS manifestations, and literature review. Clin Rheumatol. 2020;39(12):3853\u201360. https:\/\/doi.org\/10.1007\/s10067-020-05210-4.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1876_CR14","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/art.41549","volume":"73","author":"O Schnappauf","year":"2021","unstructured":"Schnappauf O, Sampaio Moura N, Aksentijevich I, et al. Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2. Arthritis Rheumatol. 2021;73(3):512\u20139. https:\/\/doi.org\/10.1002\/art.41549.","journal-title":"Arthritis Rheumatol"},{"key":"1876_CR15","doi-asserted-by":"publisher","unstructured":"Caorsi R, Penco F, Grossi A, et al. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study [published correction appears in Ann Rheum Dis. 2019 Jul;78(7):e73]. Ann Rheum Dis. 2017;76(10):1648\u20131656. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210802","DOI":"10.1136\/annrheumdis-2016-210802"},{"issue":"8S","key":"1876_CR16","doi-asserted-by":"publisher","first-page":"S509","DOI":"10.1097\/RHU.0000000000001145","volume":"27","author":"S Krutzke","year":"2021","unstructured":"Krutzke S, Horneff G. Treatment of two boys suffering from deficiency of adenosine deaminase type 2 (DADA2) with TNF-inhibitor etanercept. J Clin Rheumatol. 2021;27(8S):S509\u201312. https:\/\/doi.org\/10.1097\/RHU.0000000000001145.","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"1876_CR17","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/annrheumdis-2015-208491","volume":"75","author":"I Kon\u00e9-Paut","year":"2016","unstructured":"Kon\u00e9-Paut I, Shahram F, Darce-Bello M, et al. Consensus classification criteria for paediatric Beh\u00e7et\u2019s disease from a prospective observational cohort: PEDBD. Ann Rheum Dis. 2016;75(6):958\u201364. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208491.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1876_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3109\/09273948.2011.634978","volume":"20","author":"A Gul","year":"2012","unstructured":"Gul A, Ohno S. HLA-B*51 and Beh\u00e7et Disease. Ocul Immunol Inflamm. 2012;20(1):37\u201343. https:\/\/doi.org\/10.3109\/09273948.2011.634978.","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"1876_CR19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","volume":"11","author":"D McGonagle","year":"2015","unstructured":"McGonagle D, Aydin SZ, G\u00fcl A, Mahr A, Direskeneli H. \u2019MHC-I-opathy\u2019-unified concept for spondyloarthritis and Beh\u00e7et disease. Nat Rev Rheumatol. 2015;11(12):731\u201340. https:\/\/doi.org\/10.1038\/nrrheum.2015.147.","journal-title":"Nat Rev Rheumatol"},{"key":"1876_CR20","doi-asserted-by":"publisher","unstructured":"Leccese P, Padula MC, Santospirito EV, et al. The relationship between HLA-B*51 subtypes, clinical manifestations and severity of Beh\u00e7et's syndrome: a large Italian cohort study. Rheumatol Adv Pract. 2023;7(3):rkad087. Published 2023 Oct 17. https:\/\/doi.org\/10.1093\/rap\/rkad087","DOI":"10.1093\/rap\/rkad087"},{"issue":"3","key":"1876_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","volume":"54","author":"DH Verity","year":"1999","unstructured":"Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Beh\u00e7et\u2019s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999;54(3):213\u201320. https:\/\/doi.org\/10.1034\/j.1399-0039.1999.540301.x.","journal-title":"Tissue Antigens"},{"issue":"25","key":"1876_CR22","doi-asserted-by":"publisher","first-page":"14405","DOI":"10.1073\/pnas.2002051117","volume":"117","author":"K Manthiram","year":"2020","unstructured":"Manthiram K, Preite S, Dedeoglu F, et al. Common genetic susceptibility loci link PFAPA syndrome, Beh\u00e7et\u2019s disease, and recurrent aphthous stomatitis. Proc Natl Acad Sci U S A. 2020;117(25):14405\u201311. https:\/\/doi.org\/10.1073\/pnas.2002051117.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1876_CR23","doi-asserted-by":"publisher","unstructured":"Alroqi FJ, Alhezam MA, Almojali AI, et al. Novel Presentation of Major Histocompatibility Complex Class II Deficiency with Hemophagocytic Lymphohistiocytosis.\u00a0J Clin Immunol. 2024;44(3):73. Published 2024 Mar 1. https:\/\/doi.org\/10.1007\/s10875-024-01674-0","DOI":"10.1007\/s10875-024-01674-0"},{"issue":"2","key":"1876_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10875-019-00734-0","volume":"40","author":"A Tanatar","year":"2020","unstructured":"Tanatar A, Karada\u011f \u015eG, S\u00f6zeri B, et al. ADA2 Deficiency: case series of five patients with varying phenotypes. J Clin Immunol. 2020;40(2):253\u20138. https:\/\/doi.org\/10.1007\/s10875-019-00734-0.","journal-title":"J Clin Immunol"},{"key":"1876_CR25","doi-asserted-by":"publisher","unstructured":"Colangelo A, Tromby F, Cafaro G, Gerli R, Bartoloni E, Perricone C. Vasculitis associated with adenosine deaminase 2 deficiency: at the crossroads between Beh\u00e7et's disease and autoinflammation. A viewpoint.\u00a0Reumatismo. 2023;75(3):https:\/\/doi.org\/10.4081\/reumatismo.2023.1578. Published 2023 Sep 18. https:\/\/doi.org\/10.4081\/reumatismo.2023.1578","DOI":"10.4081\/reumatismo.2023.1578"},{"issue":"8","key":"1876_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.930","volume":"11","author":"D Nicoar\u0103","year":"2023","unstructured":"Nicoar\u0103 D, Ni\u021b\u0103 C, Stanil\u0103 A, et al. A new CECR1 mutation associated with severe hematological involvement in ADA2 deficiency. Immun Inflamm Dis. 2023;11(8): e930. https:\/\/doi.org\/10.1002\/iid3.930.","journal-title":"Immun Inflamm Dis"},{"key":"1876_CR27","doi-asserted-by":"publisher","unstructured":"Asna Ashari K, Aslani N, Parvaneh N, et al. A case series of ten plus one deficiency of adenosine deaminase 2 (DADA2) patients in Iran.\u00a0Pediatr Rheumatol Online J. 2023;21(1):55. Published 2023 Jun 13. https:\/\/doi.org\/10.1186\/s12969-023-00838-3","DOI":"10.1186\/s12969-023-00838-3"},{"key":"1876_CR28","unstructured":"Van Well GTJ, Kant B, van Nistelrooij A, et al. Phenotypic variability including Beh\u00e7et's disease-like manifestations in DADA2 patients due to a homozygous c.973\u20132A>G splice site mutation.\u00a0Clin Exp Rheumatol. 2019;37 Suppl 121(6):142\u2013146."},{"issue":"7","key":"1876_CR29","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41431-018-0130-6","volume":"26","author":"M Rama","year":"2018","unstructured":"Rama M, Duflos C, Melki I, et al. A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience. Eur J Hum Genet. 2018;26(7):960\u201371. https:\/\/doi.org\/10.1038\/s41431-018-0130-6.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"1876_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00296-017-3740-3","volume":"38","author":"S Sahin","year":"2018","unstructured":"Sahin S, Adrovic A, Barut K, et al. Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency. Rheumatol Int. 2018;38(1):129\u201336. https:\/\/doi.org\/10.1007\/s00296-017-3740-3.","journal-title":"Rheumatol Int"},{"issue":"4","key":"1876_CR31","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.jaci.2018.01.012","volume":"141","author":"L Trotta","year":"2018","unstructured":"Trotta L, Martelius T, Siitonen T, et al. ADA2 deficiency: Clonal lymphoproliferation in a subset of patients. J Allergy Clin Immunol. 2018;141(4):1534-1537.e8. https:\/\/doi.org\/10.1016\/j.jaci.2018.01.012.","journal-title":"J Allergy Clin Immunol"},{"key":"1876_CR32","doi-asserted-by":"publisher","unstructured":"Xu Y, Shan Y, Hu Y, et al. Case Report: An Adult Patient With Deficiency of Adenosine Deaminase 2 Resembled Unilateral Frosted Branch Angiitis.\u00a0Front Med (Lausanne). 2021;8:642454. Published 2021 Apr 29. https:\/\/doi.org\/10.3389\/fmed.2021.642454","DOI":"10.3389\/fmed.2021.642454"},{"issue":"6","key":"1876_CR33","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.ajo.2008.06.019","volume":"146","author":"RO Ka\u00e7maz","year":"2008","unstructured":"Ka\u00e7maz RO, Kempen JH, Newcomb C, et al. Ocular inflammation in Beh\u00e7et disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol. 2008;146(6):828\u201336. https:\/\/doi.org\/10.1016\/j.ajo.2008.06.019.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1876_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/jocd.15920","volume":"23","author":"B Yuxuan","year":"2024","unstructured":"Yuxuan B, Yan D. Adenosine deaminase 2 deficiency in a Chinese patient: Report of one novel mutation and literature review. J Cosmet Dermatol. 2024;23(1):68\u201375. https:\/\/doi.org\/10.1111\/jocd.15920.","journal-title":"J Cosmet Dermatol"},{"key":"1876_CR35","doi-asserted-by":"publisher","unstructured":"Maccora I, Maniscalco V, Campani S, et al. A wide spectrum of phenotype of deficiency of deaminase 2 (DADA2): a systematic literature review.\u00a0Orphanet J Rare Dis. 2023;18(1):117. Published 2023 May 13. https:\/\/doi.org\/10.1186\/s13023-023-02721-6","DOI":"10.1186\/s13023-023-02721-6"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01876-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-025-01876-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01876-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:44:55Z","timestamp":1777304695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-025-01876-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1876"],"URL":"https:\/\/doi.org\/10.1007\/s10875-025-01876-0","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"27 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patients\u2019 parents have consented to the submission of the report to the journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}],"article-number":"83"}}